Shubham Mathur

Beersheba, D 84105, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Trimeric Class I Viral Fusion Protein Vaccine Immunogens Using a Trimeric Autotransporter in a Killed Whole-Cell Bacteria Vaccine Platform: Applications to HIV MPER.

Trimeric Class I Viral Fusion Protein Vaccine Immunogens Using a Trimeric Autotransporter in a Killed Whole-Cell Bacteria Vaccine Platform: Applications to HIV MPER.

Journal: Viruses

Published: June 10, 2026

HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines.

HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines.

Journal: Viruses

Published: December 23, 2025

Engineering Enhanced Immunogenicity of Surface-Displayed Immunogens in a Killed Whole-Cell Genome-Reduced Bacterial Vaccine Platform Using Class I Viral Fusion Peptides.

Engineering Enhanced Immunogenicity of Surface-Displayed Immunogens in a Killed Whole-Cell Genome-Reduced Bacterial Vaccine Platform Using Class I Viral Fusion Peptides.

Journal: Vaccines

Published: November 20, 2025

The association of Helicobacter pylori infection and inflammation with cognitive development in preadolescents.

The association of Helicobacter pylori infection and inflammation with cognitive development in preadolescents.

Journal: Pediatrics and neonatology

Published: August 09, 2025

Detection and quantification of SARS-CoV-2 in wastewater using a mobile laboratory setting.

Detection and quantification of SARS-CoV-2 in wastewater using a mobile laboratory setting.

Journal: Letters in applied microbiology

Published: August 19, 2024

Metagenomic sequencing for investigation of a national keratoconjunctivitis outbreak, Israel, 2022.

Metagenomic sequencing for investigation of a national keratoconjunctivitis outbreak, Israel, 2022.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: August 03, 2023

Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.

Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.

Journal: Vaccines

Published: December 23, 2021

Protein Biomarker Identification for the Discrimination of Brucella melitensis Field Isolates From the Brucella melitensis Rev.1 Vaccine Strain by MALDI-TOF MS.

Protein Biomarker Identification for the Discrimination of Brucella melitensis Field Isolates From the Brucella melitensis Rev.1 Vaccine Strain by MALDI-TOF MS.

Journal: Frontiers in microbiology

Published: May 20, 2021

Genomic Analysis of Natural Rough Brucella melitensis Rev.1 Vaccine Strains: Identification and Characterization of Mutations in Key Genes Associated with Bacterial LPS Biosynthesis and Virulence.

Genomic Analysis of Natural Rough Brucella melitensis Rev.1 Vaccine Strains: Identification and Characterization of Mutations in Key Genes Associated with Bacterial LPS Biosynthesis and Virulence.

Journal: International journal of molecular sciences

Published: September 30, 2020

Postgenomics Characterization of an Essential Genetic Determinant of Mammary Pathogenic Escherichia coli.

Postgenomics Characterization of an Essential Genetic Determinant of Mammary Pathogenic Escherichia coli.

Journal: mBio

Published: April 05, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026